Xian Li

No. 301 Yan Chang Zhong Road
Shanghai, 200072, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Synergistic Modulation of the Tumor Microenvironment by Ultrasound-Assisted Fecal Microbiota Transplantation to Reverse Anti-PD-1 Resistance in Colorectal Cancer.

Synergistic Modulation of the Tumor Microenvironment by Ultrasound-Assisted Fecal Microbiota Transplantation to Reverse Anti-PD-1 Resistance in Colorectal Cancer.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: February 10, 2026

A novel prognostic model based on MVIRGs identifies ANGPT2 as a key target driving the malignant progression of HCC.

A novel prognostic model based on MVIRGs identifies ANGPT2 as a key target driving the malignant progression of HCC.

Journal: Biological procedures online
Published: January 31, 2026

Serum 5'-tiRNA-iMet-CAT is a novel biomarker for the diagnosis and early postoperative assessment of hepatocellular carcinoma.

Serum 5'-tiRNA-iMet-CAT is a novel biomarker for the diagnosis and early postoperative assessment of hepatocellular carcinoma.

Journal: World journal of surgical oncology
Published: November 24, 2025

Liver regeneration-associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition.

Liver regeneration-associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition.

Journal: Science advances
Published: August 22, 2025

Serum tRF-18-HR05X6D2 may serve as a promising potential diagnostic biomarker for gastric cancer.

Serum tRF-18-HR05X6D2 may serve as a promising potential diagnostic biomarker for gastric cancer.

Journal: Clinical and experimental medicine
Published: August 10, 2025

5'-transfer RNA halve-lysine-CTT as a promising biomarker for early detection of hepatocellular carcinoma.

5'-transfer RNA halve-lysine-CTT as a promising biomarker for early detection of hepatocellular carcinoma.

Journal: World journal of gastrointestinal oncology
Published: June 25, 2025

Serum STARD4-AS1 as a Novel Marker for Gastric Cancer Diagnosis and Promotes Gastric Cancer Progression.

Serum STARD4-AS1 as a Novel Marker for Gastric Cancer Diagnosis and Promotes Gastric Cancer Progression.

Journal: Clinical and translational gastroenterology
Published: March 18, 2025

Self-Powered α Radionuclide Nanomedicine: Mitochondria-Targeted Multimodal Energy Recycling for Amplified Radioimmunotherapy.

Self-Powered α Radionuclide Nanomedicine: Mitochondria-Targeted Multimodal Energy Recycling for Amplified Radioimmunotherapy.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: March 08, 2025

Visual and Quantitative 18F-FDG PET Tumor-liver Ratio in Radioiodine Refractory Differentiated Thyroid Cancer: Prognostic and Potential Predictive Value.

Visual and Quantitative 18F-FDG PET Tumor-liver Ratio in Radioiodine Refractory Differentiated Thyroid Cancer: Prognostic and Potential Predictive Value.

Journal: Molecular imaging and biology
Published: November 04, 2024

Targeting senescence with radioactive 223Ra/Ba SAzymes enables senolytics-unlocked One-Two punch strategy to boost anti-tumor immunotherapy.

Targeting senescence with radioactive 223Ra/Ba SAzymes enables senolytics-unlocked One-Two punch strategy to boost anti-tumor immunotherapy.

Journal: Biomaterials
Published: August 15, 2024

Effects of the subtypes of apolipoprotein E on immune inhibition and prognosis in patients with Hepatocellular Carcinoma.

Effects of the subtypes of apolipoprotein E on immune inhibition and prognosis in patients with Hepatocellular Carcinoma.

Journal: Journal of cancer research and clinical oncology
Published: April 13, 2024

Potential clinical significance of ALDH3B1 in auxiliary diagnosis of gastric cancer.

Potential clinical significance of ALDH3B1 in auxiliary diagnosis of gastric cancer.

Journal: Biomarkers in medicine
Published: February 09, 2024
Showing 1-12 of 21

Last Updated: 09/26/2026